2026 AHA/ASA Acute Ischemic Stroke Guideline

Featured image of the 2026 AHA/ASA Acute Ischemic Stroke Guideline with EKG line, heart icon, and gold badge on a navy blue background.

What is the 2026 AHA/ASA Acute Ischemic Stroke Guideline?

The 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke provides comprehensive, evidence-based recommendations for stroke care from prehospital evaluation through acute treatment and early in-hospital management. It replaces previous guidelines with updated evidence on thrombolytic choice, endovascular thrombectomy eligibility, and new pediatric recommendations.

Introduction

Every year, more than 600,000 individuals in the United States experience a first ischemic stroke, making it one of the most critical conditions encountered in emergency and neurological medicine. 
The 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke represents the most current and comprehensive evidence available in acute ischemic stroke care, replacing the 2018 guidelines and the 2019 update. 
This authoritative document from the American Heart Association and American Stroke Association serves as an essential resource for healthcare professionals dedicated to improving stroke outcomes.
This guideline addresses the full continuum of care—from prehospital evaluation through acute treatment and early in-hospital management of complications. 
It incorporates significant advances in stroke medicine, including new evidence on thrombolytic choice and eligibility, eligibility criteria for endovascular thrombectomy, and management of hyperglycemia and dysphagia. For the first time, it includes focused recommendations for the pediatric population. 
The intended audience includes prehospital care professionals, physicians, allied health professionals, and hospital administrators, making it an indispensable reference across the stroke care continuum.

Book Overview

  • Full Title: 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association
  • Guideline Writing Group Chair: Shyam Prabhakaran, MD, MS, FAHA
  • Vice Chairs: Nestor R. Gonzalez, MD, MSCR, FAHA; Kori S. Zachrison, MD, MSc, FAHA
  • Publisher: American Heart Association / American Stroke Association
  • Publication Year: 2026
  • Medical Specialty: Vascular Neurology, Emergency Medicine, Neurointerventional Surgery, Neurocritical Care
  • Intended Audience: Prehospital care professionals, emergency physicians, neurologists, neurointerventionalists, neurosurgeons, neurocritical care physicians, nurses, hospital administrators, medical students, residents, and fellows
  • Endorsing Organizations: American Association of Neurological Surgeons/Congress of Neurological Surgeons, Neurocritical Care Society, Society for Academic Emergency Medicine, Society of Neurointerventional Surgery, Society of Vascular and Interventional Neurology

What This Book Covers

The 2026 AHA/ASA Acute Ischemic Stroke Guideline provides comprehensive coverage of the full spectrum of acute ischemic stroke management. The guideline is organized into six major sections that follow the patient journey from symptom onset through hospitalization.
  • Stroke Systems of Care and Prehospital Management: This section addresses population-level stroke awareness, emergency medical services systems, prehospital assessment and management, EMS destination management, and the role of mobile stroke units. It emphasizes the importance of coordinated regional stroke systems to increase access to time-sensitive therapies and recommends that hospitals participate in accountable stroke systems of care.
  • Emergency Evaluation and Treatment: This section covers stroke scales, initial vascular and multimodal imaging approaches, and other diagnostic tests. It provides detailed recommendations on the use of the NIH Stroke Scale, imaging protocols for thrombolysis and thrombectomy eligibility, and the role of ECG and troponin testing in the acute evaluation.
  • General Supportive Early Management: This comprehensive section includes recommendations on airway and breathing management, head positioning, blood pressure management, temperature management, blood glucose management, intravenous thrombolytics, endovascular thrombectomy, antiplatelet treatment, anticoagulants, volume expansion, vasodilators, hemodynamic augmentation, neuroprotective agents, and emergency carotid endarterectomy.
  • In-Hospital Management of AIS – General Supportive Care: This section covers stroke units, dysphagia management, nutrition, deep vein thrombosis prophylaxis, depression screening and treatment, other in-hospital management considerations, and rehabilitation.
  • In-Hospital Management of AIS—Treatment of Acute Complications: This section addresses brain swelling (general recommendations, medical management, and surgical management for both supratentorial and cerebellar infarction) and seizures.

Key Features

  • Evidence-Based Recommendations: All recommendations are graded with Class of Recommendation and Level of Evidence, providing clear guidance on the strength and quality of supporting evidence.
  • Pediatric Focus: For the first time, the guideline includes comprehensive recommendations for pediatric patients with acute ischemic stroke, addressing imaging, thrombolysis, and endovascular thrombectomy in children.
  • Updated Thrombolytic Guidance: New recommendations endorse the use of either alteplase or tenecteplase in the 4.5-hour treatment window, with tenecteplase offering practical advantages as a single bolus injection.
  • Expanded Endovascular Thrombectomy Criteria: Recent evidence supports expanding EVT to populations previously considered ineligible, including patients with larger ischemic core strokes.
  • Posterior Circulation Stroke Recommendations: Strong recommendations for EVT in patients with basilar artery occlusion presenting within 24 hours of symptom onset.
  • Blood Pressure Management Updates: New evidence guides BP management after IVT and EVT, with recommendations against intensive systolic BP reduction to <140 mm Hg even with complete reperfusion.
  • Mobile Stroke Unit Guidance: Updated recommendations support the use of MSUs over conventional EMS where available.
  • Practical Management Tables: Includes tables for thrombolysis dosing, management of symptomatic intracranial bleeding, and management of orolingual angioedema.

Who Should Read This Book

  • Medical Students: Provides a comprehensive foundation in acute stroke management, essential for neurology and emergency medicine rotations.
  • Residents: An indispensable resource for neurology, emergency medicine, and neurosurgery residents preparing for board examinations and clinical practice.
  • Fellows: Critical reading for vascular neurology, neurointerventional, and neurocritical care fellows.
  • Emergency Physicians: Essential reference for rapid evaluation and treatment decisions in the emergency department.
  • Neurologists: Provides comprehensive updates on the latest evidence in acute ischemic stroke management.
  • Neurointerventionalists: Detailed guidance on patient selection and procedural techniques for endovascular thrombectomy.
  • Nurses and Advanced Practice Providers: A valuable resource for understanding stroke protocols and evidence-based care.
  • Hospital Administrators: Guidance on stroke systems of care and hospital certification requirements.

Why This Book Is Useful

  • Clinical Relevance: The guideline directly impacts clinical decision-making in the acute stroke setting, where time-sensitive interventions can dramatically improve patient outcomes. The recommendations are immediately applicable to daily practice.
  • Evidence-Based Content: All recommendations are based on a systematic review of the highest-quality evidence available, including randomized controlled trials and meta-analyses. The guideline incorporates studies published through March 2025, ensuring current evidence informs clinical practice.
  • Practical Applications: The guideline includes specific dosing protocols, management algorithms, and practical tables for managing complications such as symptomatic intracranial bleeding and orolingual angioedema.
  • Board Examination Preparation: The comprehensive coverage of acute stroke management makes this guideline essential preparation for board examinations in neurology, emergency medicine, and neurosurgery.
  • Learning Efficiency: The modular knowledge-chunk format enhances user-friendliness, with each section including a table of recommendations, a brief synopsis, and supporting text. The "Top Take-Home Messages" provide a quick overview of key changes.

Table of Contents Overview

1. Introduction – Methodology, organization, scope, and classification of recommendations
2. Stroke Systems of Care and Prehospital Management – Stroke awareness, EMS systems, prehospital assessment and management, EMS destination management, mobile stroke units, hospital stroke capabilities, emergency evaluation, telemedicine, organization and integration of components, stroke registries, and quality improvement
3. Emergency Evaluation and Treatment – Stroke scales, initial vascular and multimodal imaging approaches, other diagnostic tests
4. General Supportive Early Management – Airway and breathing, head positioning, blood pressure management, temperature management, blood glucose management, IV thrombolytics (decision-making, choice of agent, extended time windows, other fibrinolytics, specific circumstances), endovascular thrombectomy (concomitant with IVT, adult patients, posterior circulation, techniques, pediatric patients), antiplatelet treatment, anticoagulants, volume expansion and vasodilators, neuroprotective agents, emergency carotid endarterectomy
5. In-Hospital Management of AIS: General Supportive Care – Stroke units, dysphagia, nutrition, deep vein thrombosis prophylaxis, depression, other management considerations, rehabilitation
6. In-Hospital Management of AIS: Treatment of Acute Complications – Brain swelling (general recommendations, medical management, supratentorial infarction, cerebellar infarction), seizures

Strengths of the Book

  1. Comprehensive Coverage: The guideline covers the entire patient journey from prehospital evaluation through acute treatment and early in-hospital management, providing a complete reference for stroke care.
  2. Evidence-Based Approach: All recommendations are supported by systematic evidence review, with clear grading of recommendation strength and evidence quality.
  3. Current Evidence: Incorporates the latest evidence through March 2025, ensuring clinicians have access to the most up-to-date guidance.
  4. Practical Clinical Tools: Includes dosing tables, management algorithms, and practical guidance for managing complications, facilitating immediate clinical application.
  5. Multidisciplinary Perspective: The writing group includes representatives from multiple specialties and professional organizations, ensuring comprehensive and balanced recommendations.
  6. Patient-Centered Approach: Includes shared decision-making guidance and addresses patient preferences and values.
  7. Pediatric Inclusion: The first AHA/ASA acute stroke guideline to include comprehensive pediatric recommendations, addressing a previously underserved population.

Limitations

  • Complexity: The comprehensive nature of the guideline may be overwhelming for readers seeking quick reference; however, the modular format and Top Take-Home Messages help address this.
  • Generalizability: While applicable to most patients, individual clinical circumstances may require deviation from recommendations, which the guideline acknowledges.
  • Resource Requirements: Some recommendations, such as mobile stroke units, may not be feasible in all healthcare settings due to resource constraints.

Comparison With Similar Books

The 2026 AHA/ASA Acute Ischemic Stroke Guideline differs from other stroke resources in several important ways:

  • Comprehensive Scope: Unlike textbooks focused on specific aspects of stroke care, this guideline covers the entire spectrum of acute management from prehospital to in-hospital care.
  • Evidence-Based Grading: Provides a clear class of recommendation and level of evidence for each recommendation, helping clinicians understand the strength of supporting evidence.
  • Timeliness: Incorporates the most current evidence, including studies published through March 2025, making it more current than most textbooks.
  • Multidisciplinary Consensus: Developed with input from multiple professional organizations, ensuring broad acceptance and applicability.



Or: Link 2


FAQs

  • What are the major changes in the 2026 AHA/ASA Acute Ischemic Stroke Guideline?
The guideline includes new evidence on thrombolytic choice (endorsing both alteplase and tenecteplase), expanded endovascular thrombectomy criteria, new pediatric recommendations, updated blood pressure management guidance, and recommendations for mobile stroke units.
  • What are the key recommendations for intravenous thrombolysis in acute ischemic stroke?
Tenecteplase at 0.25 mg/kg (maximum 25 mg) or alteplase at 0.9 mg/kg is recommended within 4.5 hours of symptom onset for patients with disabling deficits. Tenecteplase offers practical advantages as a single bolus injection.
  • When is endovascular thrombectomy recommended for acute ischemic stroke?
EVT is recommended for patients with anterior circulation proximal large vessel occlusion presenting within 24 hours of symptom onset with appropriate imaging selection, including patients with larger ischemic core strokes.
  • Are there recommendations for pediatric patients with acute ischemic stroke?
Yes, this is the first AHA/ASA acute stroke guideline with comprehensive pediatric recommendations, addressing imaging, thrombolysis (IV alteplase may be considered), and endovascular thrombectomy in children.
  • What are the new recommendations for blood pressure management after thrombolysis?
Intensive systolic BP reduction to less than 140 mm Hg is not recommended after IVT, as it does not improve functional outcomes. After EVT, intensive systolic BP reduction to <140 mm Hg is harmful and not recommended.
  • How should dysphagia be managed in patients with acute ischemic stroke?
Bedside swallow screening is recommended before oral intake. Pharyngeal electrical stimulation is a new treatment option that can reduce dysphagia severity and aspiration risk.
  • What are the recommendations for antiplatelet therapy in minor stroke?
For patients with minor noncardioembolic stroke or high-risk TIA, dual antiplatelet therapy should be initiated early (within 24 hours) and continued for 21 days, followed by single antiplatelet therapy.

Conclusion

The 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke represents a landmark update in stroke care, providing comprehensive, evidence-based recommendations that directly impact patient outcomes. 
With its expanded pediatric focus, updated thrombolytic guidance, and refined endovascular thrombectomy criteria, this guideline equips healthcare professionals with the tools needed to deliver optimal acute stroke care. 
The clear recommendation grading, practical clinical tools, and multidisciplinary consensus make this an essential reference for medical students, residents, practicing physicians, and healthcare administrators alike. 
As stroke remains a leading cause of death and disability, familiarity with these guidelines is not just academically valuable—it is clinically imperative for improving patient outcomes and reducing the burden of stroke worldwide.

Disclaimer

MedBook 4 Free does not own copyrights to this video/book/software. We’re sharing this with our audience ONLY for educational purposes, and we highly encourage our visitors to purchase original licensed software/books.

If someone with copyrights wants us to remove this software/book, please contact us immediately. You can send an email to [email protected] for all DMCA / removal requests.

Comments